Timeline Overview: Filing vs. Registration

Date:

Share post:






How long does NMPA filing take for cosmetics in China? | China Gateway 360


NMPA filing for ordinary cosmetics in China takes a total of 2 to 5 months from the start of document preparation to receiving a valid filing number, while NMPA registration for special cosmetics takes 6 to 12 months due to additional toxicological testing and technical review. The actual timeline depends on 8 key variables: product category, safety assessment completeness, CNAS testing turnaround, Chinese responsible person readiness, regulatory review efficiency, deficiency rounds during review, regulatory reform cycles, and seasonal calendar bottlenecks.

Timeline Overview: Filing vs. Registration

The distinction between ordinary cosmetics filing (备案, bèi’àn) and special cosmetics registration (注册, zhùcè) is the most important factor determining your timeline. Filing follows a “notification upon submission” model where the number issues immediately upon document completeness check, followed by a post-filing review. Registration requires pre-market approval — no notification shortcut exists. Understanding which category your product falls into is the first and most consequential decision in your China market entry roadmap.

For ordinary cosmetics: Phase 1 (preparation) takes 4 to 12 weeks for CNAS testing, safety assessment, and document compilation; Phase 2 (submission) takes 1 to 5 business days for filing number issuance; Phase 3 (post-filing review) takes 30 to 90 days. The product can generally be sold during Phase 3, but if the review finds deficiencies, sale must stop within 30 days of the notice. This conditional market access during the post-filing window is one of the key advantages of the filing pathway versus the full registration route.

For special cosmetics: Phase 1 (preparation) takes 12 to 20 weeks for designated lab toxicological testing (3 to 6 months) plus efficacy evaluation (4 to 12 weeks); Phase 2 submits the dossier; Phase 3 (technical review) takes 90 working days (approximately 4.5 months) and is often extended by 1 to 2 deficiency rounds adding 2 to 4 months. Special cosmetics have no grace period — no product may be sold or distributed until the registration certificate is issued.

Phase Ordinary Cosmetics Filing Special Cosmetics Registration
CRP appointment 2–4 weeks 2–4 weeks
Safety testing 4–8 weeks (CNAS lab) 12–24 weeks (designated lab)
Safety assessment compilation 4–8 weeks 4–8 weeks
Efficacy evaluation N/A 4–12 weeks
Online submission + filing number 1–5 business days N/A (registration, not filing)
Technical review (NMPA) Post-filing: 30–90 days 90 working days + deficiency rounds
Deficiency correction 2–4 weeks per round 4–8 weeks per round
Total (no deficiencies) 2–5 months 6–9 months
Total (with deficiencies) 3–7 months 8–14 months

Phase-by-Phase Breakdown

The longest phase for ordinary cosmetics filing is CNAS-accredited testing. Microbiology testing takes 2 to 3 weeks, heavy metal screening 1 to 2 weeks, and accelerated stability testing (40°C/75% RH) takes 12 weeks minimum — the NMPA expects at least 12 weeks of accelerated data for the filing. Safety assessment compilation takes 4 to 8 weeks depending on formulation complexity: a simple 10-ingredient moisturizer takes 4 weeks, while a 30-ingredient product with complex actives takes 8 weeks. Brands should also budget time for the CNAS lab booking queue, which can add 2 to 6 weeks in peak periods.

The Chinese responsible person (CRP) appointment is often underestimated. If the brand has a China WFOE, this takes 2 weeks. Engaging a third-party CRP takes 3 to 4 weeks including due diligence, contract negotiation, and notarization. The NMPA’s post-filing substantive review typically completes within 30 to 60 days for most foreign brand filings, though the statutory window is 90 days. Brands should also factor in the 1 to 2 weeks needed to obtain a CRP entity’s business license and bank account verification documents.

Testing bottlenecks deserve special attention. Designated testing labs for special cosmetics are concentrated in Beijing, Shanghai, and Guangzhou, with total capacity of approximately 800 to 1,200 sets of toxicological tests per year. During peak season (March to June), lab wait times can stretch from the advertised 12 weeks to 18 or even 20 weeks. Brands filing special cosmetics are strongly advised to reserve testing slots 60 to 90 days in advance of the desired start date.

Factors Affecting Timelines

  • Product category: General moisturizers and cleansers — fastest (2–3 months). Cosmetics with active ingredients needing additional safety justification — moderate (3–5 months). Products with borderline classification — slowest (5–7 months). The NMPA’s 2021 classification guidance and the 2025 updated catalogue provide detailed rules, but grey-zone products (e.g., anti-dandruff shampoos, fluoride toothpastes, acne treatments) often require a pre-submission classification inquiry that adds 4 to 6 weeks.
  • Laboratory selection: Tier-1 city labs have 4 to 8 week queues; smaller city labs may have 1 to 3 week queues but less imported cosmetics experience. Overseas CNAS-recognized labs may be faster for certain tests. However, the NMPA has been tightening acceptance of overseas testing data — as of 2026, only CNAS-accredited overseas labs with an active mutual recognition agreement (MRA) with China are accepted without supplementary domestic testing.
  • Safety assessor experience: An assessor familiar with NMPA formatting requirements can reduce compilation time by 2 to 4 weeks compared to a first-time assessor. The 2024 CSAR implementing rules introduced a standardized safety assessment template (Annex 3-1), which has somewhat narrowed the gap between experienced and inexperienced assessors but has also increased the documentation volume by approximately 30%.
  • Regulatory consultant: Brands using a China-based cosmetics regulatory consultant reduce average filing time by 30 to 40%. A good consultant not only speeds document preparation but also manages constructive deficiency responses — anticipating common review questions and pre-emptively addressing them can eliminate one full deficiency round.
  • Regulatory reform cycles: The IECIC (Inventory of Existing Cosmetic Ingredients in China) is updated approximately every 12 to 18 months. Each IECIC update triggers a 6- to 8-week adjustment period during which the NMPA’s cosmetic registration and filing system (CRS-I) undergoes backend updates and ingredient code remapping. Submissions that reference newly added or recategorized ingredients may be flagged for manual review, adding 3 to 6 weeks beyond the standard timeline. Brands should check whether their key ingredients have been affected by the most recent IECIC update before initiating the filing process. The 2025 IECIC update, for example, added 387 new ingredients and changed the hazard classification status of 52 existing entries, causing a processing backlog of approximately 1,200 filings in Q2 2025.
  • Seasonal and calendar bottlenecks: The fourth quarter (October to December) and the Chinese New Year period (late January to mid-February) see significant slowdowns in NMPA processing. During Q4, NMPA review departments undergo annual performance assessment and budget review, reducing effective review capacity by an estimated 25 to 35%. During Chinese New Year, the CRS-I online system is partially closed for maintenance for 10 to 14 days, and lab workers return to their home provinces, extending testing timelines by 3 to 5 weeks. Brands filing in December risk having their application sit untouched for the first three weeks of January. The optimal submission windows are March to May and September to October, when NMPA reviewer capacity is highest.

Real-World Examples

Scenario Product Type CRP Setup Testing Safety/Efficacy Review Total
A — Korean skincare Ordinary (moisturizer) 2 wks (WFOE) 5 wks 6 wks 45 days 4 months
B — French fragrance Ordinary (perfume) 3 wks (3rd party) 4 wks 5 wks 90 days 6 months
C — US sunscreen Special (SPF 50+) 2 wks (WFOE) 24 wks 6 wks 6 months 11 months

Cost Implications of Timeline Delays

Every month of delay in NMPA approval carries a direct financial cost that many brands underestimate. For a typical imported cosmetics brand entering China, the baseline gross merchandise value (GMV) contribution from a single SKU during the first year of market entry is approximately RMB 500,000 per month. This figure is based on the average performance of imported prestige cosmetics brands on Tmall Global and Douyin during their first 12 months of active listing, assuming a product retail price of RMB 200 to 400 per unit and monthly sales volumes of 1,250 to 2,500 units.

Revenue loss per delay month: Each additional month that a product spends in the NMPA pipeline rather than on the shelf represents RMB 500,000 in foregone GMV. For ordinary cosmetics, a delay from 3 months to 6 months (a common outcome when deficiencies are identified) costs approximately RMB 1.5 million in lost first-year revenue. For special cosmetics, a delay from 9 months to 14 months costs approximately RMB 2.5 million in lost revenue. These figures do not account for the compounding effect of lost repeat purchases, brand awareness growth, and seasonal sales peaks (e.g., Singles’ Day in November, which alone accounts for 20 to 30% of annual Tmall sales).

Expediting budget — cost-benefit analysis: Brands can reduce timeline risk by allocating an expediting budget. The following cost ranges reflect current market rates in 2026:

  • Premium testing slot booking: RMB 15,000 to 30,000 per product. Tier-1 labs in Shanghai and Beijing offer priority processing that reduces testing time by 3 to 5 weeks for an additional fee of 30 to 50% above base testing charges.
  • Pre-audit dossier review: RMB 20,000 to 50,000 per submission. A former NMPA reviewer or senior regulatory specialist reviews the complete dossier before submission for common deficiency triggers, reducing the probability of a deficiency letter from ~40% to ~10%.
  • Dedicated case manager at a regulatory consultancy: RMB 8,000 to 15,000 per month retainer. Ensures real-time tracking of submission status and rapid response to deficiency notices — a 24-hour response to a deficiency notice can save 2 to 4 weeks compared to a standard 7-day response cycle.
  • Full-service expedited program: RMB 80,000 to 150,000 flat fee (ordinary) or RMB 200,000 to 350,000 (special). Combines premium testing, pre-audit review, dedicated case management, and ongoing regulatory monitoring through the post-filing period. Firms using this tier typically hit the 2- to 3-month ordinary filing timeline versus 4 to 5 months without it.

Total expediting ROI: Spending RMB 80,000 to 150,000 to reduce an ordinary filing timeline from 5 months to 2 months saves approximately RMB 1.5 million in accelerated GMV (3 months × RMB 500,000), yielding a return on investment of 10:1 to 19:1. For special cosmetics, the ROI is even more pronounced: RMB 200,000 to 350,000 in expediting costs against RMB 2.5 million in saved delay cost yields an ROI of 7:1 to 12:1. Brands that treat expediting as a budget line item rather than an afterthought consistently achieve faster market entry and higher first-year GMV.

Hidden costs of delay: Beyond direct revenue loss, brands should consider three additional cost categories: (1) inventory holding costs — products manufactured and shipped to China awaiting final NMPA approval incur warehousing charges of RMB 500 to 2,000 per pallet per month; (2) marketing window loss — if a product misses the November Singles’ Day seasonal peak, the effective annual GMV impact is closer to RMB 800,000 to 1,000,000 per delay month due to the concentrated nature of Chinese e-commerce sales; and (3) competitive erosion — each month of delay allows a competing brand with parallel product positioning to establish loyalty and market share that is expensive to reclaim.

Market Entry Alternatives While Waiting for NMPA Approval

While the NMPA filing or registration process is underway, brands can explore three parallel or interim market entry pathways that generate revenue, build brand awareness, and establish distribution relationships before the full NMPA approval arrives.

CBDIC (Cross-Border Direct Import Channel) bridge: The cross-border e-commerce channel, commonly referred to as the CBDIC bridge or the “bonded warehouse model,” allows foreign cosmetics to be sold to Chinese consumers without individual NMPA filing, provided the sale is conducted through a cross-border e-commerce platform (Tmall Global, JD Worldwide, Douyin Global, Kaola) and the consumer purchases directly from an overseas warehouse or a bonded warehouse in China’s comprehensive bonded zones. Products are classified as personal-use items under the CBEC (Cross-Border E-Commerce) pilot program. Key considerations: (1) no NMPA filing number is required, so the product can go live on cross-border platforms in 4 to 8 weeks versus 2 to 12 months for NMPA approval; (2) per-transaction purchase limits apply — RMB 5,000 per order and RMB 26,000 per person per year; (3) the brand does not need a Chinese entity nor a CRP, though a third-party cross-border operations partner is strongly recommended; and (4) after achieving 3 to 6 months of cross-border sales data, the brand can use that data to demonstrate market demand when preparing the full NMPA filing, often improving negotiation leverage with retail partners. The CBDIC bridge is best suited for brands launching their first China product or testing category acceptance before committing to the full NMPA process.

Hainan FTP (Free Trade Port) pilot: Hainan Province operates under a separate regulatory framework as China’s Free Trade Port. Cosmetics sold within Hainan’s duty-free retail ecosystem enjoy several filing simplifications compared to mainland China. Under the Hainan FTP cosmetics pilot policy (implementation guidance issued March 2024, updated January 2026): (1) ordinary cosmetics may be sold in Hainan duty-free stores with a simplified filing that takes 3 to 4 weeks versus 2 to 5 months for mainland NMPA filing; (2) the simplified filing requires only basic safety data (microbiology, heavy metals, formulation declaration) rather than the full safety assessment required for mainland filing; (3) products sold through Hainan must be physically present on the island — they cannot be shipped from the mainland to fulfill Hainan orders; and (4) the Hainan simplified filing is valid only for sales within Hainan’s duty-free ecosystem and does not constitute NMPA approval for mainland distribution. Hainan duty-free sales reached RMB 58.5 billion in 2025, representing a significant standalone market opportunity. Brands can enter Hainan while the full NMPA mainland filing is processing, then transition to mainland distribution once the NMPA certificate is issued. Note that the Hainan pilot is subject to review and potential modification — brands should confirm current policy status with the Hainan Provincial Drug Administration before committing to this pathway.

Duty-free travel retail: China’s airport duty-free and downtown duty-free (DFS) channels operate under a separate customs supervision framework. Cosmetics sold in duty-free stores to departing international travelers or to travelers entering China (arrival duty-free) are not subject to NMPA cosmetics filing requirements, provided the products are imported under the duty-free bonded warehouse regime. Key advantages: (1) no NMPA timeline — products can move from factory to duty-free shelf in 8 to 12 weeks, limited only by production lead time, customs clearance, and duty-free retailer listing approval; (2) brand exposure to China’s most valuable cosmetics consumers — CDFG (China Duty Free Group), which operates 80% of China’s duty-free stores, reported average duty-free cosmetics spend of RMB 3,800 per transaction in 2025; (3) the duty-free channel serves as an effective brand-building platform — many prestige brands enter China via duty-free 6 to 12 months before securing NMPA approval for full mainland distribution, using the duty-free presence to educate consumers and generate social media buzz on Xiaohongshu (Little Red Book); and (4) duty-free sales generate valuable consumer data that can inform mainland product positioning, pricing strategy, and marketing creative. The primary drawback is channel exclusivity — most major duty-free operators require an exclusive listing arrangement for the first 12 to 24 months, which can complicate subsequent mainland distribution negotiations.

Strategic sequencing recommendation: The most cost-effective market entry sequence for imported cosmetics brands in 2026 is: (1) launch on CBDIC cross-border e-commerce (weeks 1 to 8) to begin generating sales and consumer feedback; (2) simultaneously initiate Hainan FTP simplified filing (weeks 4 to 8) to establish a duty-free retail presence; (3) file the full NMPA ordinary cosmetics application (weeks 4 to 20) using cross-border sales data to support the safety assessment and market justification; and (4) after NMPA approval (months 4 to 7), expand to full mainland wholesale distribution, Tmall flagship store (non-cross-border), domestic retail chains (Sephora China, Watsons, Mariemekko), and offline specialty stores. This parallel-track strategy allows a brand to achieve 6 to 12 months of revenue generation before the NMPA certificate arrives, dramatically improving the first-year financial profile of the China market entry.

Post-Filing Obligations

Receiving the filing number is not the end. Under CSAR Article 43, the CRP must retain documents for 5 years after the product is discontinued. The NMPA conducts random post-market surveillance on approximately 2% of filed products annually — samples must be provided within 10 business days. Any formulation change, facility change, or CRP change requires a new filing or amendment (备案变更), typically taking 2 to 4 weeks for simple changes. Non-compliance with post-filing obligations can result in suspension of the filing number and potential fines of RMB 10,000 to 100,000 under the 2024 CSAR enforcement guidelines.

  1. Verify your NMPA filing number: Ordinary: 国妆网备进字(YYYY)第XXXX号. Special: 国妆特字(YYYY)第XXXX号. Ensure label matches the certificate. Display the number on all product packaging and e-commerce listings.
  2. Register in platform databases: Each e-commerce platform (Douyin, JD, Tmall) has its own product listing approval referencing the NMPA number (3 to 10 business days). Cross-border platforms require separate registration using the Hainan filing number or CBEC record-keeping number.
  3. Set up adverse event monitoring: CRP must have a system to report within 24 hours (serious) or 30 days (non-serious). The NMPA launched a digital adverse event reporting portal in 2025 that integrates with most major ERP systems.
  4. Schedule annual safety data review: CRP should review new safety data published for ingredients and assess filing validity. The 2025 CSAR update introduced a mandatory annual safety data review submission for special cosmetics.
  5. Plan renewal timeline: Special cosmetics certificates are valid for 5 years. Begin renewal 6 to 8 months before expiry. Ordinary cosmetics filings are valid indefinitely unless the product is reformulated or the CRP changes.

Where to Go From Here

Based on what you just read:

How long does NMPA filing take for cosmetics in China? — first published on China Gateway 360. Last updated: July 2026.


Related articles

What is the difference between CCC and GB standards in China?

CCC vs GB Standards: Key Differences and Compliance Requirements for China Market Entry Navigating China’s regulatory landscape requires distinguishin

Can a foreign company apply for CCC certification directly?

Can a foreign company apply for CCC certification directly? No, a foreign company cannot apply for China Compulsory Certification (CCC, 中国强制性产品认证, zhō

How long does CCC certification take for imported products?

How long does CCC certification take for imported products? body{font-family:Arial,Helvetica,sans-serif;line-height:1.8;color:#333;max-width:960px;mar

China Patent Law Amendment Review: What It Means for Pharma IP Protection

China Patent Law Amendment Review: What It Means for Pharma IP Protection The Fourth Amendment to China's 专利法 (Patent Law, zhuānlì fǎ), effective June